Antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in Spain, 2004-2014

Journal of Global Antimicrobial Resistance

Volumn 6, Issue , 2016, Pages 50-56

  Marco, Francesc ^a   Dowzicky, Michael J ^b  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b PFIZER INC   (United States)

Author keywords

Antimicrobial resistance; Spain; Surveillance; Tigecycline

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFEPIME; CEFTRIAXONE; LEVOFLOXACIN; LINEZOLID; MACROLIDE; MEROPENEM; MINOCYCLINE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; KLEBSIELLA OXYTOCA; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIC90; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; ANALOGS AND DERIVATIVES; DRUG EFFECT; ENTEROCOCCUS; KLEBSIELLA; MICROBIAL SENSITIVITY TEST; SPAIN; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; ESCHERICHIA COLI; KLEBSIELLA; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; SPAIN; STAPHYLOCOCCUS AUREUS;

EID: 84963677291     PISSN: 22137165     EISSN: 22137173     Source Type: Journal    
DOI: 10.1016/j.jgar.2016.02.005     Document Type: Article

References (31)

1. S.E. Cosgrove The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs Clin Infect Dis 42 Suppl. 2 2006 S82 S89
2. G. Patel, S. Huprikar, S.H. Factor, S.G. Jenkins, and D.P. Calfee Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies Infect Control Hosp Epidemiol 29 2008 1099 1106
3. C. Rubio-Terrés, J. Garau, S. Grau, L. Martinez-Martinez Cast of Resistance Study Group Cost of bacteraemia caused by methicillin-resistant vs. methicillin-susceptible Staphylococcus aureus in Spain: a retrospective cohort study Clin Microbiol Infect 16 2010 722 728
4. European Centre for Disease Prevention and Control Antimicrobial resistance surveillance in Europe, 2011. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2011 ECDC Stockholm, Sweden http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2011.pdf [accessed 22.10.15]
5. European Centre for Disease Prevention and Control ECDC surveillance report. Surveillance of antimicrobial consumption in Europe, 2012. Stockholm Sweden: ECDC; 2012, http://ecdc.europa.eu/en/publications/Publications/antimicrobial-consumption-europe-esac-net-2012.pdf [accessed 05.11.15]
6. European Centre for Disease Prevention and Control Antimicrobial resistance surveillance in Europe, 2013. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2013 ECDC Stockholm, Sweden http://ecdc.europa.eu/en/publications/-layouts/forms/Publication-DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1205 [accessed 22.10.15]
7. A.C. Rodloff, R. Leclercq, E.A. Debbia, R. Cantón, B.A. Oppenheim, and M.J. Dowzicky Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the Tigecycline Evaluation and Surveillance Trial Clin Microbiol Infect 14 2008 307 314
8. J. Aznar, J.A. Lepe, and M.J. Dowzicky Antimicrobial susceptibility among E. faecalis and E. faecium from France, Germany, Italy, Spain and the UK (T.E.S.T. Surveillance Study, 2004-2009) J Chemother 24 2012 74 80
9. N. Nørskov-Lauritsen, H. Marchandin, and M.J. Dowzicky Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007) Int J Antimicrob Agents 34 2009 121 130
10. O. Denis, C. Nonhoff, and M.J. Dowzicky Antimicrobial susceptibility among Gram-positive and Gram-negative isolates collected in Europe between 2004 and 2010 J Glob Antimicrob Resist 2 2014 155 161
11. V. Cattoir, and M.J. Dowzicky A longitudinal assessment of antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in France between 2004 and 2012 Antimicrob Resist Infect Control 3 2014 36
12. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard - ninth edition. Document M07-A9 2012 CLSI Wayne, PA
13. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters. Version 4.0 2014 http://www.eucast.org/clinical-breakpoints/ [accessed 22.10.15]
14. World Health Organization Antimicrobial resistance: global report on surveillance 2014 WHO Geneva, Switzerland http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748-eng.pdf?ua=1 [accessed 22.10.15]
15. M. Sánchez García, M.A. De la Torre, G. Morales, B. Peláez, M.J. Tolón, S. Domingo, and et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit JAMA 303 2010 2260 2264
16. G. Morales, J.J. Picazo, E. Baos, F.J. Candel, A. Arribi, B. Peláez, and et al. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus Clin Infect Dis 50 2010 821 825
17. F. Perez, A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather, and R.A. Bonomo Global challenge of multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 51 2007 3471 3484
18. M. del Mar Tomas, M. Cartelle, S. Pertega, A. Beceiro, P. Llinares, D. Canle, and et al. Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection Clin Microbiol Infect 11 2005 540 546
19. A.Y. Peleg, H. Seifert, and D.L. Paterson Acinetobacter baumannii: emergence of a successful pathogen Clin Microbiol Rev 21 2008 538 582
20. C.J. Henwood, T. Gatward, M. Warner, D. James, M.W. Stockdale, R.P. Spence, and et al. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936) J Antimicrob Chemother 49 2002 479 487
21. M.L. Mezzatesta, G. Trovato, F. Gona, V.M. Nicolosi, D. Nicolosi, A. Carattoli, and et al. In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy Ann Clin Microbiol Antimicrob 7 2008 4
22. C. Betriu, I. Rodríguez-Avial, B.A. Sánchez, M. Gómez, J. Alvarez, and J.J. Picazo In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain Antimicrob Agents Chemother 46 2002 892 895
23. J.C. Sánchez-Gómez, F. Fraile-Malmierca, E.D. Valverdé-Romero, M. Sánchez, J.A. García-Rodríguez, and J.E. García-Sánchez Linezolid-resistant Enterococcus faecalis: first report in Spain J Chemother 18 2006 440 442
24. R. Gómez-Gil, M.P. Romero-Gómez, A. García-Arias, M.G. Ubeda, M.S. Busselo, R. Cisterna, and et al. Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital Diagn Microbiol Infect Dis 65 2009 175 179
25. A.M. Sánchez-Díaz, C. Cuartero, S. Lozano, J.D. Rodríguez, J.M. Alonso, I. Quiles-Melero, and et al. Emergence and long-lasting persistence of linezolid-resistant Enterococcus faecium-ST117 in an oncohematologic patient after a nine-day course of linezolid Microb Drug Resist 20 2014 17 21
26. G. Werner, T.M. Coque, A.M. Hammerum, R. Hope, W. Hryniewicz, A. Johnson, and et al. Emergence and spread of vancomycin resistance among enterococci in Europe Eur Surveill 13 2008 47
27. M.A. Díaz, J.R. Hernández, L. Martínez-Martínez, J. Rodríguez-Baño, and A. Pascual Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006) Enferm Infecc Microbiol Clin 27 2009 503 510 [in Spanish]
28. J. Oteo, E. Miró, M. Pérez-Vázquez, and F. Navarro Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future? Enferm Infecc Microbiol Clin 32 Suppl. 4 2014 17 23
29. Z.R. Palacios-Baena, J. Oteo, C. Conejo, M.N. Larrosa, G. Bou, M. Fernández-Martínez, and et al. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain J Infect 72 2016 152 160
30. C. Betriu, I. Rodríguez-Avial, M. Gómez, E. Culebras, F. López, J. Alvarez, and et al. Antimicrobial activity of tigecycline against clinical isolates from Spanish medical centers. Second multicenter study Diagn Microbiol Infect Dis 56 2006 437 444
31. M. Hornsey, M.J. Ellington, M. Doumith, S. Hudson, D.M. Livermore, and N. Woodford Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome J Antimicrob Chemother 65 2010 479 482